Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines
Authors:
- I HennebelleIHI Hennebelle
- P CanalPCP Canal
- R BugatRBR Bugat
- S GuichardSGS Guichard
- 1 January 2003
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 39 (1) , 112-119
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- MutS Preferentially Recognizes Cisplatin- over Oxaliplatin-modified DNAJournal of Biological Chemistry, 2002
- In vitro studies on the mechanisms of oxaliplatin resistanceCancer Chemotherapy and Pharmacology, 2001
- High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)European Journal of Cancer, 2001
- Effect of DNA Polymerases and High Mobility Group Protein 1 on the Carrier Ligand Specificity for Translesion Synthesis past Platinum−DNA AdductsBiochemistry, 1999
- In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cellsCarcinogenesis, 1996
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996
- Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cellsCancer Letters, 1996
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracilEuropean Journal of Cancer, 1990
- Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethalityBiochemistry, 1990